tradingkey.logo

Dr Reddy's Laboratories Ltd

RDY
14.200USD
+0.260+1.87%
收盘 12/19, 16:00美东报价延迟15分钟
11.82B总市值
17.32市盈率 TTM

Dr Reddy's Laboratories Ltd

14.200
+0.260+1.87%

关于 Dr Reddy's Laboratories Ltd 公司

Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.

Dr Reddy's Laboratories Ltd简介

公司代码RDY
公司名称Dr Reddy's Laboratories Ltd
上市日期Jan 01, 1986
CEOAghanian (Patrick)
员工数量27811
证券类型Depository Receipt
年结日Jan 01
公司地址8-2-337, Road No.3 Banjara Hills
城市HYDERABAD
上市交易所NASDAQ OMX NASDAQ Basic NYSE
国家India
邮编500-034
电话914049002900
网址https://www.drreddys.com/
公司代码RDY
上市日期Jan 01, 1986
CEOAghanian (Patrick)

Dr Reddy's Laboratories Ltd公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Deepak Sapra
Mr. Deepak Sapra
Chief Executive Officer - API and Services
Chief Executive Officer - API and Services
--
--
Mr. Sanjiv Soshil Mehta
Mr. Sanjiv Soshil Mehta
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Phanimitra (Phani) B
Mr. Phanimitra (Phani) B
Chief Digital and Information Officer
Chief Digital and Information Officer
--
--
Mr. Mannam Venkata Narasimham
Mr. Mannam Venkata Narasimham
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Richa Periwal
Ms. Richa Periwal
Investor Relations
Investor Relations
--
--
Kodumudi Pranatharthiharan Krishnan
Kodumudi Pranatharthiharan Krishnan
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. K. Randhir Singh
Mr. K. Randhir Singh
Compliance Officer, Company Secretary, Head - CSR
Compliance Officer, Company Secretary, Head - CSR
--
--
Mr. Kallam Satish Reddy
Mr. Kallam Satish Reddy
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Ms. Chan (Penny) Wan
Ms. Chan (Penny) Wan
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Arun Madhavan Kumar
Mr. Arun Madhavan Kumar
Non-Executive Independent Director
Non-Executive Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Deepak Sapra
Mr. Deepak Sapra
Chief Executive Officer - API and Services
Chief Executive Officer - API and Services
--
--
Mr. Sanjiv Soshil Mehta
Mr. Sanjiv Soshil Mehta
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Phanimitra (Phani) B
Mr. Phanimitra (Phani) B
Chief Digital and Information Officer
Chief Digital and Information Officer
--
--
Mr. Mannam Venkata Narasimham
Mr. Mannam Venkata Narasimham
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Richa Periwal
Ms. Richa Periwal
Investor Relations
Investor Relations
--
--
Kodumudi Pranatharthiharan Krishnan
Kodumudi Pranatharthiharan Krishnan
Non-Executive Independent Director
Non-Executive Independent Director
--
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2026Q1
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
United States
427.18M
42.77%
Other
309.06M
30.94%
India
179.87M
18.01%
Russia
82.79M
8.29%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 12月11日 周四
更新时间: 12月11日 周四
持股股东
股东类型
持股股东
持股股东
占比
Robeco Institutional Asset Management B.V.
1.57%
Aperio Group, LLC
1.20%
RBC Global Asset Management (UK) Limited
1.17%
Renaissance Technologies LLC
1.05%
Aikya Investment Management Limited
0.81%
其他
94.20%
持股股东
持股股东
占比
Robeco Institutional Asset Management B.V.
1.57%
Aperio Group, LLC
1.20%
RBC Global Asset Management (UK) Limited
1.17%
Renaissance Technologies LLC
1.05%
Aikya Investment Management Limited
0.81%
其他
94.20%
股东类型
持股股东
占比
Investment Advisor
6.56%
Investment Advisor/Hedge Fund
4.39%
Hedge Fund
1.20%
Research Firm
1.12%
Pension Fund
0.33%
Family Office
0.19%
Family Office
0.10%
Family Office
0.10%
Bank and Trust
0.08%
其他
85.93%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
516
112.51M
13.51%
-15.88M
2025Q2
504
118.15M
14.19%
-12.22M
2025Q1
506
114.84M
13.80%
-17.55M
2024Q4
478
124.61M
14.96%
-2.62M
2024Q3
462
118.95M
14.28%
-16.57M
2024Q2
445
126.18M
15.15%
-4.51M
2024Q1
437
124.83M
14.99%
-5.58M
2023Q4
427
125.49M
15.07%
-4.37M
2023Q3
406
119.09M
14.31%
-4.07M
2023Q2
397
109.36M
13.16%
-3.97M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Robeco Institutional Asset Management B.V.
12.16M
1.46%
+1.45M
+13.56%
Jun 30, 2025
Aperio Group, LLC
9.26M
1.11%
+2.30M
+33.13%
Jun 30, 2025
RBC Global Asset Management (UK) Limited
9.33M
1.12%
+281.97K
+3.12%
Jun 30, 2025
Renaissance Technologies LLC
9.01M
1.08%
-182.10K
-1.98%
Jun 30, 2025
Aikya Investment Management Limited
6.35M
0.76%
+154.60K
+2.49%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
5.40M
0.65%
-64.08K
-1.17%
Jun 30, 2025
The Vanguard Group, Inc.
4.98M
0.6%
-27.59K
-0.55%
Jun 30, 2025
Parametric Portfolio Associates LLC
4.28M
0.51%
+631.20K
+17.32%
Jun 30, 2025
State Street Investment Management (US)
4.19M
0.5%
+131.99K
+3.25%
Jun 30, 2025
BNP Paribas Securities Corp. North America
4.01M
0.48%
-569.44K
-12.42%
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
National Security Emerging Markets Index ETF
0.91%
Invesco S&P Emerging Markets Low Volatility ETF
0.39%
Lattice Hartford Multifactor Emerging Markets ETF
0.33%
DFA Dimensional Emerging Markets Value ETF
0.22%
ActivePassive International Equity ETF
0.18%
SPDR MSCI Emerging Markets StrategicFactors ETF
0.15%
DFA Dimensional Emerging Mkts High Proftblty ETF
0.13%
SPDR Portfolio Emerging Markets ETF
0.12%
Avantis Emerging Markets Equity ETF
0.12%
SP Funds S&P World (ex-US) ETF
0.12%
查看更多
National Security Emerging Markets Index ETF
占比0.91%
Invesco S&P Emerging Markets Low Volatility ETF
占比0.39%
Lattice Hartford Multifactor Emerging Markets ETF
占比0.33%
DFA Dimensional Emerging Markets Value ETF
占比0.22%
ActivePassive International Equity ETF
占比0.18%
SPDR MSCI Emerging Markets StrategicFactors ETF
占比0.15%
DFA Dimensional Emerging Mkts High Proftblty ETF
占比0.13%
SPDR Portfolio Emerging Markets ETF
占比0.12%
Avantis Emerging Markets Equity ETF
占比0.12%
SP Funds S&P World (ex-US) ETF
占比0.12%

分红派息

近5年累计派现 332.70M 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
May 09, 2024
RDY.NB Final Cash Dividend of gross USD 0.476153 paid on Aug 12, 2024 going ex on Jul 30, 2024
Jul 15, 2024
Aug 12, 2024
Jul 30, 2024
May 11, 2023
RDY.NB Final Cash Dividend of gross USD 0.482608 paid on Aug 11, 2023 going ex on Jul 28, 2023
Jul 10, 2023
Aug 11, 2023
Jul 28, 2023
May 24, 2022
RDY.NB Final Cash Dividend of gross USD 0.378434 paid on Aug 12, 2022 going ex on Aug 01, 2022
Jul 11, 2022
Aug 12, 2022
Aug 01, 2022
Jun 16, 2021
RDY.NB Final Cash Dividend of gross USD 0.336485 paid on Aug 11, 2021 going ex on Jul 30, 2021
Jul 09, 2021
Aug 11, 2021
Jul 30, 2021
Jun 26, 2020
RDY.NB Final Cash Dividend of gross USD 0.333364 paid on Aug 17, 2020 going ex on Jul 10, 2020
Jul 13, 2020
Aug 17, 2020
Jul 10, 2020

拆合股

公告日期
类型
比率
Oct 07, 2024
Split
1→5
公告日期
类型
比率
Oct 07, 2024
Split
1→5

常见问题

Dr Reddy's Laboratories Ltd的前五大股东是谁?

Dr Reddy's Laboratories Ltd 的前五大股东如下:
Robeco Institutional Asset Management B.V.持有股份:12.16M,占总股份比例:1.46%。
Aperio Group, LLC持有股份:9.26M,占总股份比例:1.11%。
RBC Global Asset Management (UK) Limited持有股份:9.33M,占总股份比例:1.12%。
Renaissance Technologies LLC持有股份:9.01M,占总股份比例:1.08%。
Aikya Investment Management Limited持有股份:6.35M,占总股份比例:0.76%。

Dr Reddy's Laboratories Ltd的前三大股东类型是什么?

Dr Reddy's Laboratories Ltd 的前三大股东类型分别是:
Robeco Institutional Asset Management B.V.
Aperio Group, LLC
RBC Global Asset Management (UK) Limited

有多少机构持有Dr Reddy's Laboratories Ltd(RDY)的股份?

截至2025Q3,共有516家机构持有Dr Reddy's Laboratories Ltd的股份,合计持有的股份价值约为112.51M,占公司总股份的13.51%。与2025Q2相比,机构持股有所增加,增幅为-0.68%。

哪个业务部门对Dr Reddy's Laboratories Ltd的收入贡献最大?

在FY2026Q1,--业务部门对Dr Reddy's Laboratories Ltd的收入贡献最大,创收--,占总收入的--%。
KeyAI